Melanoma Clinical Trials

Showing 621-640 of 1,292 trials

Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial

NCT03769285

A common long-term side effect of anti-rejection (immunosuppressant) medications is skin cancer. This pilot clinical trial evaluates the feasibility of conducting a larger pivotal trial to examine the efficacy and safety of nicotinamide for prevention of keratinocyte carcinoma in solid organ transplant recipients. This pilot trial will transition into the pivotal trial if all feasibility targets are met.

Non-melanoma Skin CancerCarcinoma, Squamous CellCarcinoma, Basal Cell

Women's College Hospital120 participantsStarted Dec 2018

Toronto, Ontario, Canada

COMPLETEDPhase 1

Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery

NCT02120222

This phase I clinical trial studies the side effects of selinexor in treating patients with melanoma that cannot be removed by surgery. Drugs used in chemotherapy, such as selinexor, may stop the growth of tumor cells, by stopping them from dividing.

Recurrent Melanoma

Kari Kendra8 participantsStarted Aug 2014

Columbus, Ohio, United States

TERMINATEDPhase 1/2

Study of Temzolomide and Gleevec in Advanced Melanoma

NCT00667953

This study has been designed to evaluate the side effects of Gleevec when given in combination with Temzolomide; and to learn more about how these drugs work in the body and whether this combination is useful in treating patients with melanoma.

MelanomaAdvanced Melanoma

Abramson Cancer Center at Penn Medicine32 participantsStarted Jan 2003

Philadelphia, Pennsylvania, United States

Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial

Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery

Study of Temzolomide and Gleevec in Advanced Melanoma

Related Searches

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor

Optical Frequency Domain Imaging for Non-melanoma Skin Cancers

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab

A Study of ADXS-NEO Expressing Personalized Tumor Antigens

Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma

Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma

A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma

The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Interest and Impact of Skin Cancer Genetic Testing

Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma